Amgen-wont-collaborate-with-GSK-on-Prolia
Amgen won't collaborate with GSK on Prolia
Amgen announced that the company is goint to step back from collaborating with GSK. The two pharmaceutical giants have signed an contract and GSK commercialized the osteoporosis drug of Amgen However, amgen does not want ot contribute woth GlaxoSmithKline anymore....
Tags: GlaxoSimithKline, GSK, Prolia, osteoporosis, amgen...
April 9, 2014
Oryzon-and-Roche-prepare-epigenetics-based-treatment
Oryzon and Roche prepare epigenetics-based treatment
Oryzon Genomics and Roche work together on developing and commercializing a new drug based on lysine-specific demethylase-1, a genetic modulator. ...
Tags: Oryzon, Rochr, epigenetics...
April 9, 2014
Spero-starts-a-new-figth-against-resistant-bacteria
Spero starts a new figth against resistant bacteria
Spero has entered into a partnership with Roche based on antibiotics. The research aims to find a new treatment for resisitant bacterial infections. ...
Tags: spero. antibiotics, partnership, Roche, drugs, drug development...
April 9, 2014
Phase-III-trial-of-Amgens-drug-was-an-outstanding-success
Phase III trial of Amgen's drug was an outstanding success
Evolocumab, the new drug of Amgen has gone through Phase III. clinical trial. The result is a statistically significant reduction in low-density lipoprotein cholesterol. The new drug seems to be 66% more effective than its competitors....
Tags: drug, competitior, cholesterol, Amgen...
April 4, 2014
Pharmaceuitcal-spendings-on-DTC-marketing-is-growing
Pharmaceuitcal spendings on DTC marketing is growing
According to the recent measurments pharmaceutical companies spend 9% more on Direct-to-Consumer marketing than in last year. These data are basedon research of - as Nielsen say - the measured media. ...
Tags: Nielsen, marekting, pharma marketing...
April 4, 2014
The-USPTO-Glossary-Pilot-Program
The USPTO Glossary Pilot Program
Applications accepted into this pilot program will receive expedited processing by placing them on an examiner’s special docket prior to the first Office action, and will have special status up to issuance of a first Office action....
Tags: USPTO, programme, conference, pilot programme, pharmaceutical event...
April 4, 2014
Lemtrada-is-going-to-be-resubmitted-to-FDA-review
Lemtrada is going to be resubmitted to FDA review
Lemtrada, ths multiple sclerosis drug of Genzyme, a Sanofi company was once rejected by Food and Drug Administration. The resubmission aims to solve problems which were pointed out by FDA previously. ...
Tags: FDA, Lemtrada, multiple sclerosis, sanpfi, Genzyme, resubmission, ...
April 9, 2014
Scripps-Florida-Scientists-has-a-new-research-towards-a-better-diabetes-drug
Scripps Florida Scientists has a new research towards a better diabetes drug
The Scripps Research institute has a new foundings in the field of common diabetes drugs. Ths surprising research result are hoped to lead scientist towards a more effecite treatment for high blood sugar index. ...
Tags: diabetes, diabetes drug, the scripps research institute, scripps diabetes, drug development, diabetic...
April 9, 2014
EMA-and-TGA-collaborate-to-find-new-orphan-drugs
EMA and TGA collaborate to find new orphan drugs
The European Medicines Agency and Australian Therapeutic Goods Administration announced that they are going to contribute on developing new orphan drugs and push them to clon...
Tags: European Medicines Agency, Australian Therapeutic Goods Administration, EMA, ...
April 9, 2014
Eli-Lillys-lung-cancer-drug-is-protected-by-the-court
Eli Lilly's lung cancer drug is protected by the court
federal court decided to protect Lilly's experimental cacer drug from its generic version.The drug is going to be protected till 2022....
Tags: drug; discovery; development; patent protection; Eli Lilly; Alimta; lung cancer...
April 4, 2014
Growing-scandal-around-GSK-in-China
Growing scandal around GSK in China
Bibery scandal around GSK seems to grow in China. According to some experts this is only the biginning of a bigger setback in China's drug market. ...
Tags: china, gsk, scandal, bibery...
April 4, 2014
Scientist-see-a-new-hope-in-breast-cancer-treatments
Scientist see a new hope in breast cancer treatments
According to scientists "personal drugs" can be a new way in breast-cancer treatment. they found that almost all of the aggressively growing cells are from the sam genetic type - and via this discovery they are going to be able to develop new treatment....
Tags: treatment, drug, drug discovery, breast cancer, breast cancer drug...
April 4, 2014
MOST VIEWED

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013